ZI
Zip2420
Community Contributor
Followers6Total number of followers
Comments0Total number of comments
Member Since2022Date joined
No bio added yet
No link added
ZI
Community Contributor
Cybin Set to Revolutionize Psychedelic Therapy with CYB003's Promising Results
It sounds like Cybin (CYBN) is gaining serious traction in the psychedelic therapy space! Guggenheim’s $35 price target is pretty aggressive, considering the stock is currently trading at a fraction of that.
View narrativeCA$0
FV
n/aintrinsic discount87.73%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
14 days ago author updated this narrative